Monoclonal antibody utilization characteristics in patients with multiple myeloma
2019
This study analyzed 91 multiple myeloma patients who received two monoclonal antibodies, Daratumumab and Elotuzumab, over a year and report the adverse event profile, infusion practices and utilization of these drugs in the real world. All current reported data on monoclonal antibodies is from clini
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
19
References
2
Citations
NaN
KQI